By identifying the DNMT3A/miR-129-2-5p/Rac1 signaling pathway downstream of SNHG1 that is operative in advanced bladder cancer cells, we are in no way ruling out other potential pathways or components that might also mediate the activities of SNHG1. Here, RAC1 is linked to urinary bladder cancer.